简体
简体中文
繁體中文

未知股票 IDEX

已收盘

--

0.000

NaN.00%

华盛通华盛通
立即下载
  • 最 高--
  • 今 开--
  • 成交量 --
  • 最 低 --
  • 昨 收 --
  • 总市值 0
  • 52周最高 --
  • 市盈率 --
  • 换手率 0.00%
  • 52周最低 --
  • 委 比 0.00%
  • 总股本 1197.23万
  • 历史最高 --
  • 量 比 0
  • 振 幅 NaN.00%
  • 历史最低 --
  • 每 手 1
  • 风险率 2.92%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • A Look at Becton, Dickinson's Upcoming Earnings Report

    Becton, Dickinson (NYSE:BDX) is gearing up to announce its quarterly earnings o...

    02-06 22:00

  • TD Cowen Maintains Buy on IDEX, Raises Price Target to $250

    TD Cowen analyst Joe Giordano maintains IDEX (NYSE:IEX) with a Buy and raises the price target from $200 to $250.

    02-06 00:35

  • UPDATE 1-IDEXX forecasts 2026 above estimates, but cautious clinic visit outlook weighs on shares

    UPDATE 1-IDEXX forecasts 2026 above estimates, but cautious clinic visit outlook weighs on shares Adds share movement in paragraph 2, CEO comment in paragraph 3, analyst comment in paragraph 6 By Sahil Pandey Feb 2 (Reuters) - Animal diagnostics maker IDEXX Laboratories IDXX.O forecast 2026 revenue

    02-03 01:04

  • IDEXX Laboratories Publishes FY 2025 MD&A Report

    IDEXX Laboratories Publishes FY 2025 MD&A Report IDEXX Laboratories Inc. reported a strong fourth quarter, highlighting exceptional execution and significant strategic progress throughout the year. The company successfully scaled multiple transformative innovations and expanded its commercial presen

    02-02 23:47

  • BUZZ-U.S. STOCKS ON THE MOVE-InMode, IDEXX, Revvity

    BUZZ-U.S. STOCKS ON THE MOVE-InMode, IDEXX, Revvity Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures fell on Monday, as a violent selloff in precious metals u

    02-02 22:22

  • BUZZ-IDEXX rises after beating quarterly revenue estimates

    BUZZ-IDEXX rises after beating quarterly revenue estimates ** Shares of animal diagnostics maker IDEXX Laboratories IDXX.O rise 1.13% to $678.02 premarket ** Co reports Q4 adj. profit of $3.08/shr vs analysts' average estimate of $2.93/shr - LSEG data ** Brokerage Leerink Partners said non‑wellness

    02-02 21:06

  • IDEXX Q4 revenue rises 14%, beats analyst expectations

    IDEXX Q4 revenue rises 14%, beats analyst expectations Overview Pet healthcare innovator's Q4 revenue rose 14%, beating analyst expectations EPS for Q4 increased 18%, supported by operating margin expansion Company expects 2026 revenue growth of 7.6% - 9.6% Outlook IDEXX projects 2026 revenue betwee

    02-02 19:39

  • IDEXX reports Q4 2025 revenue of USD 1.09 billion, up 14%

    IDEXX reports Q4 2025 revenue of USD 1.09 billion, up 14% IDEXX Laboratories Inc. reported fourth quarter (Q4) 2025 revenues of USD 1.09 billion, reflecting a 14% increase compared to the prior year period. The Companion Animal Group (CAG) segment achieved reported revenue growth of 15%, while Water

    02-02 19:31

  • BRIEF-IDEXX Q4 EPS USD 3.08

    BRIEF-IDEXX Q4 EPS USD 3.08 Feb 02 (Reuters) - IDEXX Q4 EBIT margin 28.9%. Q4 revenue USD 1,091 million vs. IBES estimate USD 1,073 million Q4 gross margin 60.3% outlook FY EPS USD 14.29-14.8 outlook FY revenue USD 4,632-4,720 million

    02-02 19:30

  • DIARY-U.S. earnings week ahead

    DIARY-U.S. earnings week ahead Jan 30 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. U.S. EARNINGS Start Date Start Time RIC Company Name Event Name 02-Feb-2026 BMO APTV Aptiv PLC Q4 2025 Aptiv PLC Earnings Release 02-Feb-2026 AMC DVA DaVita Inc Q4 2025 DaVita Inc Earnings R

    01-31 01:00